ATP III Guidelines Benefit Beyond LDL-Lowering:

Slides:



Advertisements
Similar presentations
ATP III Guidelines Specific Dyslipidemias. 2 Specific Dyslipidemias: Very High LDL Cholesterol (  190 mg/dL) Causes and Diagnosis Genetic disorders –Monogenic.
Advertisements

CHOLESTEROL AND OUR LIVES الدهنيات وحياتنا
Physical Activity and Weight Loss ACSM, Weight Gain Physical activity will prevent weight gain – PA of 150 to 250 min. wk -1 with an energy equivalent.
Lipids 101 Cardiology Board Review Med-Peds Style!
Final Exam Tuesday, 6/5, 2 PM Closed book – Essay and MC/TF Determining Energy Needs – p – Indirect calorimetry – Be able to do the calculations.
Nutrition Issues: Women's Life Stages Dr. Judith Wylie-Rosett Learning Objectives Identify nutrition issues for a women: –During.
T2DM MANAGEMENT DENTAL COURSE Mohamed AlMaatouq, MD King Khalid University Hospital King Saud University.
Obesity Childhood Creeping Obesity 50% of US overweight 25% obese 12% of Health Care relate to excess fat.
Nutrition Issues: Women's Life Stages Learning Objectives Identify nutrition issues for a women: –During pregnancy focusing on high risk –In midlife to.
Understanding blood lipids and glucose How a Healthy Lifestyle can improve your numbers Susan Fullmer, PhD RD Associate Teaching Professor Nutrition, Dietetics,
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
LDL-C target levels (mg/dL)  2 RF:
METABOLIC Syndrome: a Global Perspective
Cardiovascular Health and Risk Reduction in Children and Adolescents
Midterm 5 November 2013 In class 60 minutes -start questions –5 points each From lecture 1 until end of atherosclerosis(lecture 6) inclusive.
Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
ATP III Guidelines Therapeutic Lifestyle Changes (TLC)
Lars Sjöström et al N Engl J Med 2004; 351: Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.
DIABETES IN THE ELDERLY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.
Metabolic Syndrome Darwin Deen, MD, MS Albert Einstein College of Medicine Gina Lopez, MSII Sophie Davis School of Biomedical Education.
Metabolic Syndrome: Focused on AMPK as Molecular Target for Metabolic Syndrome Bayu Lestari.
Can lifestyle moderate the burden of CVD? Evangelos Polychronopoulos, MD, MPH, PhD Asst Professor of Preventive Medicine Harokopio University.
CDA exercise guidelines 150 minutes moderate – intensity (60 – 70% of max) aerobic over minimum 3 non consecutive days PLUS resistance exercise 3.
Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.
Cardiovascular System KNH 411. Hypertension Nutrition Therapy DASH – Dietary Approaches to Stop Hypertension *Decrease sodium, saturated fat, alcohol.
Metabolic Syndrome Endocrine Block 1 Lecture Dr. Usman Ghani.
Clinical Practice Guidelines for Managing Dyslipidemias in Chronic Kidney Disease Department of Nephrology R3. Yeehyung Kim.
Management of Obesity in Diabetes Key Messages An estimated 80 to 90% of persons with type 2 diabetes are overweight or obese. A modest weight loss of.
Adult Treatment Panel III (ATP III) Guidelines
Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD
Utilizing Anti-diabetic Agents to Manage Cardiovascular Disease in T2DM Patients James LaSalle, D.O., FAAFP.
Chapter 11 Diet and Health
Therapeutic Lifestyle
Chapter 7 Metabolic syndrome
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
Diabetes Mellitus.
Cardiovascular System
Cardiovascular System
Cardiovascular System
Cardiovascular System
National Cholesterol Education Program
AIM-HIGH Niacin Plus Statin to Prevent Vascular Events
Repeat fasting lipid profile to confirm in 1-2 weeks
Back to the Basics of Dyslipidemia
Does One Size Fit All in Obesity Management?
Obesity and Dyslipidemia: How Would You Treat?
Cardiovascular System
An Update on PCSK9 Inhibitors
Developing a Heart-Healthy Life Style
New LDL-C Lipid Targets
Lipid Clinic Challenge
Obesity.
Adult Treatment Panel III (ATP III) Guidelines
Lipid Updates From Spring 2019
An Update on PCSK9 Inhibitors
Goals & Guidelines A summary of international guidelines for CHD
CHD RISK Glycemia 75g OGTT Time Metabolic Syndrome
Obesity Eppie Habashi.
Updates on Dyslipidemia
Cardiovascular System
Case 1: A 78-year-old white female with hypertension and hyperlipidemia Discussion Points: In that this patient has documented atherosclerotic vascular.
III. Treating dyslipidemias
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Specific Dyslipidemias: Very High LDL Cholesterol (>190 mg/dL)
Presentation transcript:

ATP III Guidelines Benefit Beyond LDL-Lowering: The Metabolic Syndrome as a Secondary Target of Therapy FUTURE RESEARCH

Synonyms Metabolic Syndrome Insulin resistance syndrome (Metabolic) Syndrome X Dysmetabolic syndrome Multiple metabolic syndrome FUTURE RESEARCH

Causes Metabolic Syndrome Acquired causes Overweight and obesity Physical inactivity High carbohydrate diets (>60% of energy intake) in some persons Genetic causes FUTURE RESEARCH

Therapeutic Objectives Metabolic Syndrome Therapeutic Objectives To reduce underlying causes Overweight and obesity Physical inactivity To treat associated lipid and non-lipid risk factors Hypertension Prothrombitic state Atherogenic dyslipidemia (lipid triad) FUTURE RESEARCH

Management of Overweight and Obesity Metabolic Syndrome Management of Overweight and Obesity Overweight and obesity; lifestyle risk factors Direct targets of intervention Weight reduction Enhances LDL lowering Reduce metabolic syndrome risk factors Clinical guidelines: Obesity Education Initiate Techniques of weight reduction FUTURE RESEARCH

Management of Physical Inactivity Metabolic Syndrome Management of Physical Inactivity Physical inactivity: lifestyle risk factor Direct target of intervention Increased physical activity Reduce metabolic syndrome risk factors Improves cardiovascular function Clinical guidelines: U.S. Surgeon General’s Report on Physical Activity FUTURE RESEARCH